P27487 (DPP4_HUMAN) Homo sapiens (Human)
Dipeptidyl peptidase 4 UniProtKBInterProSTRINGInteractive Modelling
766 aa; Sequence (Fasta)
Available Structures
106 Experimental Structures
Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
---|---|---|---|---|---|---|
Crystal structure of HIV-1 Tat derived nonapeptides Tat(1-9) bound to the active site of Dipeptidyl… |
Heteromer P12506; | 100 | 1×NAG; 6×NAG; 2×NAG; 1×NAG; 4×NAG; | |||
Crystal structure of MjHKU4r-CoV-1 RBD bound to hDPP4 |
Heteromer A0AAE8ZFM2; | 100 | 2×NAG; 3×NAG; 6×NAG; 1×EPE; | |||
Crystal Structure of human dipeptidyl peptidase IV in complex with a decapeptide (tNPY) at 2.3 Ang.… |
Heteromer Q9XSW6; | 100 | 2×NAG; 11×NAG; | |||
Complex structure of MERS-CoV spike RBD bound to CD26 |
Heteromer K0BRG7; | 100 | 8×NAG; 2×NAG; 4×NAG; | |||
Crystal structure of MERS-CoV complexed with human DPP4 |
Heteromer R9UQ53; | 100 | 2×NAG; 1×NAG; 5×NAG; | |||
Crystal structure of dipeptidyl peptidase IV (DPPIV or CD26) in complex with adenosine deaminase |
Heteromer P56658; | 100 | 1×NAG; 4×NAG; 2×NAG; 1×NAG; 8×NAG; 2×ZN; | |||
HIV-1 Tat protein derived N-terminal nonapeptide Trp2-Tat(1-9) bound to the active site of Dipeptid… |
Heteromer P12506; P56658; | 100 | 1×NAG; 5×NAG; 2×NAG; 1×NAG; 7×NAG; 2×ZN; | |||
Bat-derived coronavirus HKU4 uses MERS-CoV receptor human CD26 for cell entry |
Heteromer A3EX94; | 100 | 3×NAG; 1×NAG; 3×NAG; | |||
Complex structure of MjHKU4r-CoV-1 spike RBD bound to human CD26 |
Heteromer A0AAE8ZFM2; | 100 | 2×NAG; 2×NAG; 4×NAG; 2×NAG; 2×NAG; 2×NAG; 6×NAG; | |||
Crystal Structure of Human DPP4 Bound to TAK-294 | homo-4-mer | 100 | 4×LUI; 15×NAG; 1×NAG; | |||
Crystal Structure of Human DPP4 Bound to TAK-986 | homo-4-mer | 100 | 5×NAG; 4×10T; 10×NAG; | |||
Crystal Structure of Human DPP4 Bound to TAK-100 | homo-4-mer | 100 | 7×NAG; 12×NAG; 4×01T; 1×NAG; | |||
crystal structure of human apo dipeptidyl peptidase IV / CD26 | homo-2-mer | 100 | 4×NAG; | |||
Crystal structure of human depiptidyl peptidase IV (DPP-4) in complex with a prolylthiazolidine inh… | homo-2-mer | 100 | 5×NAG; 2×W61; 7×NAG; | |||
Crystal Structure Of Human Dipeptidyl Peptidase IV (DPPIV) Complex With Diprotin A | homo-2-mer | 100 | 2×NAG; 5×NAG; 5×NAG; | |||
Crystal structure of human depiptidyl peptidase IV (DPP-4) in complex with vildagliptin | homo-2-mer | 100 | 2×NAG; 6×NAG; 2×LF7; 2×GOL; 5×NAG; | |||
Crystal structure of human depiptidyl peptidase IV (DPP-4) in complex with a prolylthiazolidine inh… | homo-2-mer | 100 | 5×NAG; 2×W94; 6×NAG; | |||
Crystal structure of human depiptidyl peptidase IV (DPP-4) in complex with MP-513 | homo-2-mer | 100 | 5×NAG; 2×M51; 7×NAG; | |||
Crystal structure of Human Dipeptidyl peptidase IV | homo-2-mer | 100 | 10×NAG; | |||
Structure of DPPIV in complex with an inhibitor | homo-2-mer | 100 | 2×NAG; 2×NAG; 8×NAG; 2×34Q; | |||
The structure of DPP4 in complex with Vildagliptin | homo-2-mer | 99.86 | 7×NAG; 2×LF7; 5×NAG; 1×NA; | |||
Human dipeptidyl peptidase IV/CD26 in complex with the long-acting inhibitor Omarigliptin (MK-3102) | homo-2-mer | 99.86 | 5×NAG; 1×NA; 2×2VH; 8×NAG; | |||
The structure of DPP4 in complex with Vildagliptin Analog | homo-2-mer | 99.86 | 9×NAG; 3×NAG; 2×C8S; | |||
Human DPP4 in complex with a novel tricyclic hetero-cycle inhibitor | homo-2-mer | 99.86 | 9×NAG; 4×NAG; 2×6AJ; 1×NA; | |||
Crystal Structure Analysis of DPPIV Inhibitor | homo-2-mer | 100 | 1×NAG; 5×NAG; 2×AJH; 10×NAG; | |||
The structure of DPP-4 in complex with piperidine fused imidazopyridine 34 | homo-2-mer | 99.86 | 9×NAG; 4×NAG; 1×NA; 2×361; | |||
Human DPP4 in complex with a novel 5,5,6-tricyclic pyrrolidine inhibitor | homo-2-mer | 99.86 | 7×NAG; 4×NAG; 1×NA; 2×6DG; | |||
Human dipeptidyl peptidase IV/CD26 in complex with a novel inhibitor | homo-2-mer | 99.86 | 2×NAG; 7×NAG; 6×NAG; 1×NA; 2×605; | |||
Crystal Structure Of Human Apo Dipeptidyl Peptidase IV/CD26 | homo-2-mer | 100 | 3×NAG; 4×NAG; 1×NAG; 2×NAG; 1×NAG; 3×NAG; | |||
Human dipeptidyl peptidase IV/CD26 in complex with a fluoroolefin inhibitor | homo-2-mer | 99.86 | 9×NAG; 6×NAG; 1×NA; 2×317; | |||
Crystal structure of DPP-IV complexed with Lilly aryl ketone inhibitor | homo-2-mer | 100 | 2×U1N; | |||
Human dipeptidyl peptidase iv/cd26 in complex with a 4-aryl cyclohexylalanine inhibitor | homo-2-mer | 99.86 | 2×NAG; 7×NAG; 6×NAG; 1×NA; 2×524; | |||
HUMAN DIPEPTIDYL PEPTIDASE IV IN COMPLEX WITH A BETA AMINO ACID INHIBITOR | homo-2-mer | 99.86 | 2×NAG; 7×NAG; 6×NAG; 1×NA; 2×715; | |||
The structure of DPP4 in complex with piperidine fused benzimidazole 25 | homo-2-mer | 99.86 | 9×NAG; 4×NAG; 1×NA; 2×677; | |||
Crystal Structure of Human Dipeptidyl Peptidase IV at 2.1 Ang. Resolution. | homo-2-mer | 100 | 5×NAG; 1×NAG; 10×NAG; 1×FUC; | |||
Crystal structure of human Dipeptidyl Peptidase IV (DPP-IV) | homo-2-mer | 100 | 8×NAG; 6×HG; | |||
Human dipeptidyl peptidase 4 in complex with a diazepan-2-one inhibitor | homo-2-mer | 99.86 | 9×NAG; 5×NAG; 2×565; | |||
HUMAN DIPEPTIDYL PEPTIDASE IV/CD26 MUTANT Y547F | homo-2-mer | 99.86 | 3×NAG; 4×NAG; 1×NAG; 1×NAG; 1×NAG; 1×NAG; 3×NAG; | |||
Human Dipeptidyl peptidase IV in complex with 5-aminomethyl-6-(2,4-dichloro-phenyl)-2-(3,5-dimethox… | homo-2-mer | 100 | 8×NAG; 2×5AP; | |||
Crystal structure of dipeptidyl peptidase IV in complex with inhibitor | homo-2-mer | 99.72 | 2×NAG; 1×NAG; 3×NAG; 2×NXZ; | |||
Crystal structure of dipeptidyl peptidase IV in complex with SYR-472 | homo-2-mer | 100.0 | 4×NAG; 8×NAG; 2×6RL; | |||
Crystal structure of dipeptidyl peptidase IV in complex with TAK-322 | homo-2-mer | 100 | 6×NAG; 8×NAG; 2×T22; | |||
Human dipeptidyl peptidase iv/cd26 in complex with a 4-aryl cyclohexylalanine inhibitor | homo-2-mer | 99.86 | 2×NAG; 7×NAG; 6×NAG; 1×NA; 2×474; | |||
DPP4 complexed with compound 12a | homo-2-mer | 99.86 | 1×NAG; 12×NAG; 6×SO4; 2×2KV; | |||
Human Dipeptidyl Peptidase IV in complex with a Triazolopiperazine-based beta amino acid Inhibitor | homo-2-mer | 99.86 | 2×NAG; 7×NAG; 4×NAG; 1×NA; 2×448; | |||
Human dipeptidyl peptidase IV/CD26 in complex with a flouroolefin inhibitor | homo-2-mer | 99.86 | 9×NAG; 6×NAG; 2×315; | |||
The structure of DPP4 in complex with an oxadiazole inhibitor | homo-2-mer | 99.86 | 2×NAG; 7×NAG; 6×NAG; 1×NA; 2×3TP; | |||
Crystal structure of human DPP-IV in complex with (1S,3S, 5S)-2-[(2S)-2-AMINO-2-(3-HYDROXYTRICYCLO[… | homo-2-mer | 100 | 8×NAG; 2×BJM; | |||
Crystal structure of dipeptidyl-peptidase 4 (CD26, adenosine deaminase complexing protein 2) (DPP-I… | homo-2-mer | 100 | 2×1MD; | |||
Human dipeptidyl peptidase 4 in complex with a diazepan-2-one inhibitor | homo-2-mer | 99.86 | 2×NAG; 7×NAG; 6×NAG; 1×NA; 2×872; | |||
Crystal structure of dipeptidyl peptidase IV in complex with a pyrimidinedione inhibitor 2 | homo-2-mer | 100.0 | 3×NAG; 2×XIH; 8×NAG; | |||
Human dipeptidyl peptidase IV in complex with an alpha amino acid inhibitor | homo-2-mer | 99.86 | 2×NAG; 7×NAG; 6×NAG; 1×NA; 2×277; | |||
Human dipeptidyl peptidase IV/CD26 in complex with an inhibitor | homo-2-mer | 99.86 | 9×NAG; 6×NAG; 2×S14; | |||
human DPP-IV with carmegliptin (S)-1-((2S,3S,11bS)-2-Amino-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2… | homo-2-mer | 100 | 4×NAG; 2×B1Q; | |||
Crystal Structure Of Human Dipeptidyl Peptidase IV (DPPIV) Complex With Cyclic Hydrazine Derivatives | homo-2-mer | 100 | 2×KR2; | |||
Crystal structure of human DPP-IV in complex with BMS-744891 | homo-2-mer | 100 | 2×1WH; | |||
Crystal structure of dipeptidyl peptidase IV in complex with a pyrimidinone inhibitor 3 | homo-2-mer | 100.0 | 4×NAG; 2×RUM; 8×NAG; | |||
Crystal Structure of Human DPP4 in complex with a benzimidazole derivative | homo-2-mer | 100.0 | 3×NAG; 8×NAG; 2×B2Y; | |||
Human Dipeptidyl Peptidase IV/CD26 in complex with an inhibitor | homo-2-mer | 100 | 1×NAG; 1×NAG; 4×NAG; 1×NAG; 1×NAG; 2×NAG; 1×NAG; 3×NAG; 4×HG; 2×A3M; | |||
X-ray Structure of Novel Biaryl-Based Dipeptidyl peptidase IV inhibitor | homo-2-mer | 100 | 14×NAG; 2×JNH; | |||
Crystal structure of human dipeptidyl peptidase IV (DPP-IV) in complex with Diprotin A (IPI) | homo-2-mer | 100 | 8×NAG; | |||
Crystal structure of human DPP4 in complex with inhibitor1 | homo-2-mer | 100 | 2×8VU; | |||
Crystal structure of complex of human DPP4 and inhibitor | homo-2-mer | 100 | 8×NAG; 2×356; | |||
Crystal Structure of Human Dipeptidyl Peptidase IV (CD26) in Complex with a Reversed Amide Inhibitor | homo-2-mer | 100 | 8×NAG; 2×PS4; | |||
Crystal structure of dipeptidyl peptidase IV in complex with a pyrimidinedione inhibitor 1 | homo-2-mer | 100.0 | 3×NAG; 2×RUF; 8×NAG; | |||
Structure of human DPP-IV with HTS hit (2S,3S,11bS)-3-butyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-… | homo-2-mer | 100 | 8×NAG; 2×B2Q; | |||
Human Dipeptidyl Peptidase IV/CD26 inhibited with Diisopropyl FluoroPhosphate | homo-2-mer | 100 | 1×NAG; 1×NAG; 4×NAG; 1×NAG; 1×NAG; 2×NAG; 1×NAG; 2×DFP; 1×NAG; | |||
Structure of human DPP-IV with (2S,3S,11bS)-3-(3-Fluoromethyl-phenyl)-9,10-dimethoxy-1,3,4,6,7,11b-… | homo-2-mer | 100 | 4×NAG; 2×23Q; | |||
Human Dipeptidyl peptidase IV in complex with 1-(3,4-Dimethoxy-phenyl) -3-m-tolyl-piperidine-4-ylam… | homo-2-mer | 100 | 8×NAG; 2×GVB; | |||
Crystal Structure of human DPP-IV in complex with Anagliptin | homo-2-mer | 100 | 13×NAG; 2×SKK; | |||
Crystal Structure of DPP-IV with Compound C5 | homo-2-mer | 100 | 2×D5C; | |||
Crystal structure of human DPP4 in complex with inhibitor3 | homo-2-mer | 100 | 4×8O3; | |||
CRYSTAL STRUCTURE OF HUMAN DPP4 IN COMPLEX WITH A NOVAL HETEROCYCLIC DPP4 INHIBITOR | homo-2-mer | 99.86 | 1×NAG; 2×N7F; 12×NAG; 6×SO4; | |||
DPP4 complexed with syn-7aa | homo-2-mer | 99.86 | 1×NAG; 12×NAG; 6×SO4; 2×2KS; | |||
Human DPP4 in complex with a ligand 34a | homo-2-mer | 100 | 7×NAG; 5×NAG; 2×75N; 1×NA; | |||
Human DPP4 in complex with ligand 19a | homo-2-mer | 100 | 7×NAG; 5×NAG; 2×75L; 1×NA; | |||
Human DPP4 in complex with ligand 34p | homo-2-mer | 100 | 9×NAG; 3×NAG; 2×75M; 1×NA; | |||
Crystal structure of human dpp-iv in complex with sa-(+)-3-(aminomethyl)-4-(2,4-dichlorophenyl)-6-(… | homo-2-mer | 100 | 2×NAG; 10×NAG; 2×KXB; | |||
Human dipeptidyl peptidase IV/CD26 in complex with a cyclohexalamine inhibitor | homo-2-mer | 100 | 9×NAG; 6×NAG; 1×NA; 2×417; | |||
Crystal structure of human DPP-IV in complex with Sa-(+)-(6-(aminomethyl)-5-(2,4-dichlorophenyl)-7-… | homo-2-mer | 100 | 2×NAG; 10×NAG; 2×6A5; 1×GOL; | |||
Crystal structure of human dpp-iv in complex withsa-(+)- methyl2-(3-(aminomethyl)-4-(2,4-dichloroph… | homo-2-mer | 100 | 2×NAG; 10×NAG; 2×LGE; | |||
Crystal structure of human DPP4 in complex with inhibitor2 | homo-2-mer | 100 | 2×8OL; | |||
Crystal structure of human dpp-iv in complex with sa-(+)-3-(aminomethyl)-4-(2,4-dichlorophenyl)-6-(… | homo-2-mer | 100 | 2×NAG; 11×NAG; 2×KXA; | |||
Human DPP4 in complex with ligand 34n | homo-2-mer | 100 | 7×NAG; 5×NAG; 2×75J; 1×NA; | |||
Crystal Structure of human DPP-IV in complex with HL1 | homo-2-mer | 100 | 1×NAG; 2×HL1; 2×NAG; | |||
Crystal Structure of human DPP-IV in complex with HL2 | homo-2-mer | 100 | 1×NAG; 2×NAG; 2×9EL; | |||
complex structure of dipeptidyl peptidase IV and a oxadiazolyl ketone | homo-2-mer | 100 | 2×13Z; | |||
Crystal Structure of DPP-IV with Compound C3 | homo-2-mer | 100 | 2×D3C; | |||
Cocrystal structure of dipeptidyl-peptidase 4 with an indole scaffold inhibitor | homo-2-mer | 100 | 2×CJP; | |||
Crystal structure of human dipeptidyl peptidase IV (DPPIV) complexed with cyanopyrrolidine (C5-pro-… | homo-2-mer | 100 | 1×AAF; | |||
Crystal structure of human dipeptidyl peptidase IV (DPPIV) complexed with cyanopyrrolidine (C5-pro-… | homo-2-mer | 100 | 1×ACF; | |||
Crystal structure of human dipeptidyl peptidase IV (DPPIV) with pyrrolidine-constrained phenethylam… | homo-2-mer | 100 | 1×DLI; | |||
Crystal structure of human dipeptidyl peptidase 4 (DPP IV) with potent alkynyl cyanopyrrolidine (AB… | homo-2-mer | 100 | 1×AXD; | |||
Crystal structure of human dipeptidyl peptidase IV (DPPIV) complexed with cyanopyrrolidine (C5-pro-… | homo-2-mer | 100 | 1×ADF; | |||
Crystal structure of human dipeptidyl peptidase IV (DPP IV) complexed with ABT-341, a cyclohexene-c… | homo-2-mer | 100 | 1×KIQ; | |||
Crystal structure of human DPP-4 | homo-2-mer | 100.0 | 3×NAG; 8×NAG; 4×SY1; | |||
Crystal Structure of Human DPP4 in complex with a benzimidazole derivative | homo-2-mer | 100.0 | 2×NAG; 7×NAG; 2×7AC; | |||
Human Dipeptidyl Peptidase IV (DPP4) with piperidine-constrained phenethylamine | homo-2-mer | 100 | 1×MA9; | |||
Human Dipeptidyl Peptidase IV (DPP4) with Piperidinone-constrained phenethylamine | homo-2-mer | 100 | 1×GGO; | |||
A b-aminoacyl containing thiazolidine derivative and DPPIV complex | homo-2-mer | 100 | 2×AZV; | |||
Crystal Structure of DPP-IV with Compound C2 | homo-2-mer | 100 | 2×DC3; | |||
Crystal Structure of DPP-IV with Compound C1 | homo-2-mer | 100 | 1×D1C; | |||
dipepdyl peptidase IV in complex with inhibitor PZF | monomer | 100 | 2×NAG; 1×NAG; 1×NAG; 1×PZF; 1×LGU; | |||
Crystal structure of dipeptidyl peptidase IV in complex with inhibitor | monomer | 100 | 2×NAG; 1×NAG; 1×PF2; | |||
Crystal Structure Of Human Dipeptidyl Peptidase IV (CD26) in Complex with a Reversed Amide Inhibitor | monomer | 100 | 4×NAG; 1×FPB; | |||
Crystal Structure of human Dipeptidyl Peptidase IV in complex with a pyridopyrimidinedione analogue | monomer | 100.0 | 2×NAG; 1×0WG; 4×NAG; | |||
1 SWISS-MODEL model
Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
---|---|---|---|---|---|---|
2qt9.1.A | homo-2-mer | 0.91 | 1×NAG; 2×524; | 99.87 | ||